FDA QMSR Compliance Calls for a New Mindset | FDA 21 CFR Part 820 Evolution скачать в хорошем качестве

FDA QMSR Compliance Calls for a New Mindset | FDA 21 CFR Part 820 Evolution

As of February 2, 2026, the FDA has officially begun enforcing the Quality Management System Regulation (QMSR)—a structural shift that aligns 21 CFR Part 820 with ISO 13485 and changes how medical device manufacturers will be inspected. In Part 1 of this QT9 Q-Cast episode, host Christian Reyes is joined by Michelle Keane, QA/RA Director at ComplyGuru, to break down what QMSR actually is—and what it is not. This conversation focuses on the why behind the regulation, the FDA’s intent, and how inspections move away from clause-by-clause audits toward risk-driven system evaluation. Michelle explains why QMSR is not a simple renumbering exercise, why ISO 13485 certification alone is not enough, and how FDA-retained requirements like complaints, CAPA, MDR, traceability, and labeling remain central enforcement drivers. The episode also explores which manufacturers will feel the transition most, where legacy QSR assumptions break down, and why risk-based thinking is now embedded across the entire quality system—not just design controls. The key takeaway from Part 1 is clear: QMSR rewards organizations with connected systems, leadership accountability, and real risk ownership—while exposing fragmented processes and compliance theater. If you’re responsible for quality, regulatory, or executive oversight in medical devices or life sciences, this episode sets the foundation for understanding how FDA inspections change under QMSR before diving into implementation details. Michelle Keane QA/RA Director, ComplyGuru Lead Auditor & MDR Assessor Links & Resources • FDA Quality Management System Regulation (QMSR): https://www.fda.gov/medical-devices/p... • ComplyGuru: https://complyguru.com/ • ComplyGuru FDA QMSR Transition Training: https://complyguru.com/en-us/training... Chapters: 00:00 – QMSR Enforcement Begins 01:20 – What QMSR Is (Plain English) 03:30 – Why FDA Aligned with ISO 13485 06:15 – Why This Is Not a Renumbering Exercise 08:45 – Who Will Feel QMSR the Most 11:30 – FDA-Retained QSR Requirements 14:20 – Complaint Handling & CAPA Risk Signals 17:20 – Why ISO Certification Isn’t Enough 19:30 – Risk Beyond Design Controls 22:10 – What FDA Will Focus on First 24:30 – Key Takeaway & What Comes Next